Feb 10, 2025
1:16
For every 16 shares held, investors received 1. The price per share adjusted from $0.19 to $0.01.
The split itself did not change the total investment value.
BioXcel Therapeutics, Inc. (BTAI) trades on the NASDAQ Capital Market in the Biotechnology industry.
BioXcel Therapeutics, Inc. company overviewThe latest split shown was on February 10, 2025. It was a 1-for-16 reverse split, so shareholders received 1 share for every 16 they held.
This history records one reverse split, on February 10, 2025.